PRINCETON, NJ, USA I April 26, 2025 I UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions ...

At the European Lung Cancer Congress (ELCC) 2025, Benjamin Besse, MD, PhD, presented a keynote talk on the rationale and strategies for treatment de-escalation in lung cancer, challenging the ...

Summary: Myriad's Precise MRD test is an ultrasensitive second-generation hybrid-capture-based tumor-informed assay that ...

Tombal believes that we can use intermittent regimens in selected patients. Perhaps there are indications based on PSA response for which patients we may be able to assess for treatment de-escalation.

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

In 2024, the Springfield Police Department employed 46 officers and received 47,945 calls for service. Of those calls, 4,113 ...

PM CDT at the ASCO Annual MeetingMIAMI, April 24, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) ...

A new study reveals that heart attack survivors could greatly reduce their risk of a second event by starting combination ...

Verastem Oncology said Wednesday that the Food and Drug Administration cleared the company's investigational new drug application for its potential treatment of certain cancers. The ...

These agents have been successfully introduced into the treatment paradigms of a variety ... This Phase I dose-escalation study in patients with advanced solid tumors was performed to determine ...

sociopathy is a critical mental condition, lets understand this term and know more about its symptoms and treatment ...

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...